Annovis Bio, Inc.ANVSNYSE
LOADING
|||
Switch Symbol:
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-21.89B
↓ 697% below average
Average (7y)
$-2.75B
Historical baseline
Range
High:$-476542.00
Low:$-21.89B
CAGR
+355.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-21.89B | -54681.3% |
| 2023 | $-39.97M | -130.9% |
| 2022 | $-17.31M | -89.6% |
| 2021 | $-9.13M | -130.0% |
| 2020 | $-3.97M | -733.3% |
| 2019 | $-476542.00 | +14.7% |
| 2018 | $-558609.00 | -3.9% |
| 2017 | $-537481.00 | - |